Unverified50% confidenceBenchmarkExact time
On both the MIMIC-CXR and MIMIC-ABN datasets, ARIVE's clinical efficacy metrics outperform strong baseline models.
1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
11/11/2026
First Seen
Valid until: 2/9/2027
Sources
Related Entities
Related Claims
UnverifiedExperiments on distribution-shift benchmarks show that MIRA improves accuracy, calibration and negative log-likelihood.63% similarUnverifiedAmong the set of evaluated models, medical-adapted models have higher omission rates than general-purpose models.62% similarUnverifiedExpert blind evaluation results show that the reports generated by ARIVE are competitive with those of leading models.60% similarUnverifiedUnder the same and reduced data budget (using only 10% of the SFT data and 5% of the preference data relative to the DeepSeek-R1 distillation setting), MLR outperforms SFT-based distillation methods as well as strong RL/preference optimization baselines on multiple base models and tasks.60% similarUnverifiedAccording to the study's description, this processing noticeably improves the model's accuracy and consistency of judgment on samples involving binary payloads—the blind spot is partially filled.60% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1158107API
curl https://kongchang.com/api/v1/knowledge/claims/1158107MCP
get_claim(id=1158107)